{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:01:15Z","timestamp":1758704475871},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"All India Institute of Medical Sciences intramural grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11060-015-2047-z","type":"journal-article","created":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T12:20:40Z","timestamp":1451737240000},"page":"271-278","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of chromosome 1q gain in intracranial ependymomas"],"prefix":"10.1007","volume":"127","author":[{"given":"Madhu","family":"Rajeshwari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehar Chand","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aanchal","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Nambirajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Suri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manmohan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra Kumar","family":"Saran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,2]]},"reference":[{"key":"2047_CR1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1096-911X(199806)30:6<319::AID-MPO1>3.0.CO;2-H","volume":"30","author":"E Bouffet","year":"1998","unstructured":"Bouffet E, Perilongo G, Cavete A et al (1998) A critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 30:319\u2013329","journal-title":"Med Pediatr Oncol"},{"key":"2047_CR2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3171\/jns.1998.88.4.0695","volume":"88","author":"PL Robertson","year":"1998","unstructured":"Robertson PL, Zeltzer PM, Boyett JM et al (1998) Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children\u2019s Cancer Group. J Neurosurg 88:695\u2013703","journal-title":"J Neurosurg"},{"key":"2047_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000028637","volume":"28","author":"F Sala","year":"1998","unstructured":"Sala F, Talacchi A, Mazza C et al (1998) Prognostic factors in childhood intracranial ependymomas: the role of age and tumour location. Pediatr Neurosurg 28:135\u2013142","journal-title":"Pediatr Neurosurg"},{"key":"2047_CR4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.MP.0000087420.34166.B6","volume":"16","author":"J Zamecnik","year":"2003","unstructured":"Zamecnik J, Snuderl M, Eckschlager T et al (2003) Paediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol 16:980\u2013991","journal-title":"Mod Pathol"},{"key":"2047_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/14737175.5.4.465","volume":"5","author":"MD Krieger","year":"2005","unstructured":"Krieger MD, Bowen IE (2005) Effects of surgical resection and adjuvant therapy on pediatric intracranial ependymomas. Expert Rev Neurother 5:465\u2013471","journal-title":"Expert Rev Neurother"},{"key":"2047_CR6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/WCO.0b013e328317efe8","volume":"21","author":"R Rud\u00e0","year":"2008","unstructured":"Rud\u00e0 R, Gilbert M, Soffietti R (2008) Ependymomas of the adult: molecular biology and treatment. Curr Opin Neurol 21:754\u2013761","journal-title":"Curr Opin Neurol"},{"key":"2047_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/modpathol.3800999","volume":"21","author":"T Tihan","year":"2008","unstructured":"Tihan T, Zhou T, Holmes E, Burger PC, Ozuysal S, Rushing EJ (2008) The prognostic value of histological grading of posterior fossa ependymomas in children: a Children\u2019s Oncology Group study and a review of prognostic factors. Mod Pathol 21:165\u2013177","journal-title":"Mod Pathol"},{"key":"2047_CR8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02688699745925","volume":"11","author":"RI Ernestus","year":"1997","unstructured":"Ernestus RI, Schr\u00f6der R, St\u00fctzer H, Klug N (1997) The clinical and prognostic relevance of grading in intracranial ependymomas. Br J Neurosurg 11:421\u2013428","journal-title":"Br J Neurosurg"},{"key":"2047_CR9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0360-3016(97)00893-6","volume":"40","author":"MP McLaughlin","year":"1998","unstructured":"McLaughlin MP, Marcus RB Jr, Buatti JM et al (1998) Ependymoma: results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys 40:845\u2013850","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2047_CR10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3171\/jns.2000.93.4.0605","volume":"93","author":"D Figarella-Branger","year":"2000","unstructured":"Figarella-Branger D, Civatte M, Bouvier-Labit C et al (2000) Prognostic factors in intracranial ependymomas in children. J Neurosurg 93:605\u2013613","journal-title":"J Neurosurg"},{"key":"2047_CR11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cncr.20075","volume":"100","author":"A Korshunov","year":"2004","unstructured":"Korshunov A, Golanov A, Sycheva R et al (2004) The histological grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients. Cancer 100:1230\u20131237","journal-title":"Cancer"},{"key":"2047_CR12","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00000478-200407000-00011","volume":"28","author":"S Wolfsberger","year":"2004","unstructured":"Wolfsberger S, Fischer I, H\u00f6ftberger R et al (2004) Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma. Am J Surg Pathol 28:914\u2013920","journal-title":"Am J Surg Pathol"},{"key":"2047_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3171\/jns.2005.103.1.0031","volume":"103","author":"Y Kawabata","year":"2005","unstructured":"Kawabata Y, Takahashi JA, Arakawa Y, Hashimoto N (2005) Long-term outcome in patients harboring intracranial ependymoma. J Neurosurg 103:31\u201337","journal-title":"J Neurosurg"},{"key":"2047_CR14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cncr.21608","volume":"106","author":"E Kurt","year":"2006","unstructured":"Kurt E, Zheng PP, Hop WC et al (2006) Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas. Cancer 106:388\u2013395","journal-title":"Cancer"},{"key":"2047_CR15","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/brain\/awm046","volume":"130","author":"P Metellus","year":"2007","unstructured":"Metellus P, Barrie M, Figarella Branger D et al (2007) Multicentric French study on adult intracranial ependymomas; prognostic factor analysis and therapeutic consideration from a cohort of 152 patients. Brain 130:1338\u20131349","journal-title":"Brain"},{"key":"2047_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000120509","volume":"16","author":"LN Sutton","year":"1990","unstructured":"Sutton LN, Goldwein J, Perilongo G et al (1990) Prognostic factors in childhood ependymomas. Pediatr Neurosurg 16:57\u201365","journal-title":"Pediatr Neurosurg"},{"key":"2047_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1096-911X(199708)29:2<79::AID-MPO3>3.0.CO;2-O","volume":"29","author":"G Perilongo","year":"1997","unstructured":"Perilongo G, Massimino M, Sotti G et al (1997) Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol 29:79\u201385","journal-title":"Med Pediatr Oncol"},{"key":"2047_CR18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bjc.6600180","volume":"86","author":"M Carter","year":"2002","unstructured":"Carter M, Nicholson J, Ross F et al (2002) Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 86:929\u2013939","journal-title":"Br J Cancer"},{"key":"2047_CR19","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1078-0432.CCR-05-2363","volume":"12","author":"F Mendrzyk","year":"2006","unstructured":"Mendrzyk F, Korshunov A, Benner A et al (2006) Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12:2070\u20132079","journal-title":"Clin Cancer Res"},{"key":"2047_CR20","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0002-9440(10)63530-4","volume":"163","author":"A Korshunov","year":"2003","unstructured":"Korshunov A, Neben K, Wrobel G et al (2003) Gene expression patterns in ependymomas correlate with tumour location, grade, and patient age. Am J Pathol 163:1721\u20131727","journal-title":"Am J Pathol"},{"key":"2047_CR21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1541-7786.MCR-08-0584","volume":"7","author":"JP Kilday","year":"2009","unstructured":"Kilday JP, Rahman R, Dyer S et al (2009) Paediatric ependymoma: biological perspectives. Mol Cancer Res 7:765\u2013786","journal-title":"Mol Cancer Res"},{"key":"2047_CR22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jocn.2011.11.004","volume":"19","author":"I Yang","year":"2012","unstructured":"Yang I, Nagasawa DT, Kim W et al (2012) Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas. J Clin Neurosci 19:779\u2013785","journal-title":"J Clin Neurosci"},{"key":"2047_CR23","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2009.27.3359","volume":"28","author":"A Korshunov","year":"2010","unstructured":"Korshunov A, Witt H, Hielscher T et al (2010) Molecular staging of intracranial ependymoma in children. J Clin Oncol 28:3182\u20133190","journal-title":"J Clin Oncol"},{"key":"2047_CR24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-012-0981-9","volume":"124","author":"C Godfraind","year":"2012","unstructured":"Godfraind C, Kaczmarska JM, Kocak M et al (2012) Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol 124:247\u2013257","journal-title":"Acta Neuropathol"},{"key":"2047_CR25","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1158\/1078-0432.CCR-11-2489","volume":"18","author":"JP Kilday","year":"2012","unstructured":"Kilday JP, Mitra B, Domerg C et al (2012) Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children\u2019s Cancer Leukaemia Group (CCLG), Societe Francaise d\u2019Oncologie Pediatrique (SFOP) and International Society for Pediatric Oncology (SIOP). Clin Cancer Res 18:2001\u20132011","journal-title":"Clin Cancer Res"},{"key":"2047_CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-009-0039-6","volume":"97","author":"A Rousseau","year":"2010","unstructured":"Rousseau A, Idbaih A, Ducray F et al (2010) Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumour location, histological subtype and grade. J Neurooncol 97:353\u2013364","journal-title":"J Neurooncol"},{"key":"2047_CR27","first-page":"1346","volume":"14","author":"P Modena","year":"2012","unstructured":"Modena P, Buttarelli FR, Miceli R et al (2012) Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis. Neurooncology 14:1346\u20131356","journal-title":"Neurooncology"},{"key":"2047_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5751-10-7","volume":"10","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, Kocak M (2011) Histopathological grading of paediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10:7","journal-title":"J Negat Results Biomed"},{"key":"2047_CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00249392","volume":"7","author":"D Schiffer","year":"1991","unstructured":"Schiffer D, Chio A, Giordana MT et al (1991) Histologic prognostic factors in ependymoma. Childs Nerv Syst 7:177\u2013182","journal-title":"Childs Nerv Syst"},{"key":"2047_CR30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-2990.1998.00143.x","volume":"24","author":"L Bennetto","year":"1998","unstructured":"Bennetto L, Foreman N, Harding B et al (1998) Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas. Neuropathol Appl Neurobiol 24:434\u2013440","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2047_CR31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0165-4608(93)90200-6","volume":"71","author":"E Neumann","year":"1993","unstructured":"Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Goddard K (1993) Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 71:40\u201349","journal-title":"Cancer Genet Cytogenet"},{"key":"2047_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(99)00046-1","volume":"113","author":"C Mazewski","year":"1998","unstructured":"Mazewski C, Soukup S, Ballard E, Gotwals B, Lampkin B (1998) Karyotype studies in 18 ependymomas with literature review of 107 cases. Cancer Genet Cytogenet 113:1\u20138","journal-title":"Cancer Genet Cytogenet"},{"key":"2047_CR33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<230::AID-GCC8>3.0.CO;2-C","volume":"24","author":"DA Reardon","year":"1999","unstructured":"Reardon DA, Entrekin RE, Sublett J et al (1999) Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes Cancer 24:230\u2013237","journal-title":"Genes Chromosomes Cancer"},{"key":"2047_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/gcc.1167","volume":"32","author":"S Ward","year":"2001","unstructured":"Ward S, Harding B, Wilkins P et al (2001) Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridization in paediatric ependymoma. Genes Chromosomes Cancer 32:59\u201366","journal-title":"Genes Chromosomes Cancer"},{"key":"2047_CR35","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-9440(10)64061-8","volume":"158","author":"Y Hirose","year":"2001","unstructured":"Hirose Y, Aldape K, Bollen A et al (2001) Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158:1137\u20131143","journal-title":"Am J Pathol"},{"key":"2047_CR36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-4608(01)00624-0","volume":"135","author":"S Struski","year":"2002","unstructured":"Struski S, Doco-Fenzy M, Cornillet-Lefebvre P (2002) Compilation of published comparative genomic hybridization studies. Cancer Genet Cytogenet 135:63\u201390","journal-title":"Cancer Genet Cytogenet"},{"key":"2047_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/gcc.2870140103","volume":"14","author":"A Forus","year":"1995","unstructured":"Forus A, Weghuis DO, Smeets D et al (1995) Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14:8\u201314","journal-title":"Genes Chromosomes Cancer"},{"key":"2047_CR38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9440(10)63982-X","volume":"158","author":"S Hing","year":"2001","unstructured":"Hing S, Lu YJ, Summersgill B et al (2001) Gain of 1q is associated with adverse outcome in favorable histology Wilms\u2019 tumors. Am J Pathol 158:393\u2013398","journal-title":"Am J Pathol"},{"key":"2047_CR39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ijc.11716","volume":"109","author":"M Nilsson","year":"2004","unstructured":"Nilsson M, Meza-Zepeda LA, Mertens F et al (2004) Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer 109:363\u2013369","journal-title":"Int J Cancer"},{"key":"2047_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-4598-4-39","volume":"4","author":"SH Kresse","year":"2005","unstructured":"Kresse SH, Berner JM, Meza-Zepeda LA et al (2005) Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH. Mol Cancer 4:39","journal-title":"Mol Cancer"},{"key":"2047_CR41","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/aps.2010.94","volume":"31","author":"L Chen","year":"2010","unstructured":"Chen L, Chan TH, Guan XY (2010) Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma. Acta Pharmacol Sin 31:1165\u20131171","journal-title":"Acta Pharmacol Sin"},{"key":"2047_CR42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.2001.tb00386.x","volume":"11","author":"S Scheil","year":"2001","unstructured":"Scheil S, Br\u00fcderlein S, Eicker M et al (2001) Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 11:133\u2013143","journal-title":"Brain Pathol"},{"key":"2047_CR43","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0002-9440(10)64491-4","volume":"161","author":"S Dyer","year":"2002","unstructured":"Dyer S, Prebble E, Davison V et al (2002) Genomic imbalances in paediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161:2133\u20132141","journal-title":"Am J Pathol"},{"key":"2047_CR44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-4608(02)00516-2","volume":"136","author":"J Grill","year":"2002","unstructured":"Grill J, Avet-Loiseau H, Lellouch-Tubiana A et al (2002) Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Cancer Genet Cytogenet 136:121\u2013125","journal-title":"Cancer Genet Cytogenet"},{"key":"2047_CR45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","volume":"20","author":"H Witt","year":"2011","unstructured":"Witt H, Mack SC, Ryzhova M et al (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20:143\u2013157","journal-title":"Cancer Cell"},{"key":"2047_CR46","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/sj.bjc.6604651","volume":"99","author":"V Rand","year":"2008","unstructured":"Rand V, Prebble E, Ridley L et al (2008) Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma. Br J Cancer 99:1136\u20131143","journal-title":"Br J Cancer"},{"key":"2047_CR47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jss.2009.04.024","volume":"156","author":"D Rodriguez","year":"2009","unstructured":"Rodriguez D, Cheung MC, Housri N et al (2009) Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the surveillance, epidemiology, and end results (SEER) database (1973\u20132005). J Surg Res 156:340\u2013351","journal-title":"J Surg Res"},{"key":"2047_CR48","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1227\/00006123-199105000-00004","volume":"28","author":"MK Lyons","year":"1991","unstructured":"Lyons MK, Kelly PJ (1991) Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28:659\u2013664","journal-title":"Neurosurgery"},{"key":"2047_CR49","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0360-3016(98)00350-2","volume":"42","author":"SE Schild","year":"1998","unstructured":"Schild SE, Nisi K, Scheithauer BW et al (1998) The results of radiotherapy for ependymomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 42:953\u2013958","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2047_CR50","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cncr.20074","volume":"100","author":"M Reni","year":"2004","unstructured":"Reni M, Brandles AA, Vavassori V et al (2004) A multicentric study of the prognosis and treatment of adult brain ependymal tumours. Cancer 100:1221\u20131229","journal-title":"Cancer"},{"key":"2047_CR51","doi-asserted-by":"crossref","unstructured":"Raghunathan A, Wani K, Armstrong TS et al, Collaborative Ependymoma Research Network (2013) Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol 23:584\u2013594","DOI":"10.1111\/bpa.12050"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-2047-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2047-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T04:06:56Z","timestamp":1567483616000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-2047-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2047"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-2047-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,2]]}}}